$9.99
Explore the FDA’s classification of digital therapy devices for ADHD into class II, focusing on special controls for safety and effectiveness. This course covers compliance, implementation strategies, and industry impact, providing invaluable insights for stakeholders in the medical device sector.
In this course you will learn the following:
* Understand the classification process and criteria for the digital therapy device for ADHD.
* Identify the special controls required for compliance.
* Recognize the potential risks and mitigation measures associated with the device.
* Comprehend the consequences of non-compliance with the FDA’s final order.
NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.
Why This Course is Important
Without this course, you might miss crucial insights into compliance requirements and risk mitigation strategies vital for the successful implementation and use of digital therapy devices for ADHD.
Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Medical Devices; Neurological Devices; Classification of the Digital Therapy Device for Attention Deficit Hyperactivity Disorder.
Key regulatory references include:
Course SKU
FR-24-240-1
CourseAvenue eLearning Platform has helped Federal agencies (and their suppliers) successfully address their most complex eLearning accessibility challenges.
Federal Register Title
This benchmark will help determine your readiness for: Federal Register Document titled Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program; Correction. Document Number: 2026-04797
Buy this Course
FR-26-1798-1
Why This Course is Important
Without this course, you risk missed reimbursement opportunities, non-compliance penalties, and operational setbacks as new Medicare regulations take effect in 2028.
Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program; Correction.
Key regulatory references include:
Course SKU
FR-26-1798-1
© 2026 CourseAvenue, LLC | All rights reserved.
